by Rebecca Law | Sep 19, 2018 | CDM 2018, Hypertension |
Cardiovascular specialists have been excited about the clinical results coming in for many of our difficult to treat hyperlipidemic patients with the new PCSK9 agents. We will delve into an important discussion on the “PCSK9 Revolution” at the annual...
by Richard R. Heuser, MD, FSCAI | Aug 24, 2018 | CDM 2018, Hypertension |
Hypertension rates have been steadily growing for decades. Our health care system is now also facing an epidemic of CHF brought about by a number of factors, including untreated hypertension. As cardiologists, we see a critical opportunity aimed at addressing the...
